openPR Logo
Press release

Meningococcal Conjugate Vaccine Market in COVID-19: Implications and Opportunities for Growth in all regions

06-18-2020 05:01 PM CET | Health & Medicine

Press release from: Allied Market Research

Meningococcal Conjugate Vaccine Market

Meningococcal Conjugate Vaccine Market

Global Meningococcal Conjugate Vaccine Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).

According to a new report published by Allied Market Research, titled, “Meningococcal Conjugate Vaccine Market by Composition (Mono and Combination Vaccines); by Brand (Menveo, Menactra, Nimenrix, and NeisVac-C); and End User (Children, Preteens or Teens, and Adults) - Global Opportunities and Industry Forecasts, 2020-2027”

The Global market size of Meningococcal Conjugate Vaccine Market is $XX million in 2019 and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from 2020 to 2027.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/4143

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Sanofi Pasteur, Pfizer Inc., GlaxoSmithKline plc., Hualan Biological Engineering Inc., JN International Medical Corporation, Baxter International Inc., Merck & Co., Inc., Serum Institute of India Pvt. Ltd., Biomed Pvt. Ltd., and Novartis AG.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4143

Key Benefits
• The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
• Extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
• It offers a quantitative analysis to enable the stakeholders to capitalize on the prevailing market opportunities.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

Meningococcal Conjugate Vaccine Market Key Segments:

By Composition
• Mono Vaccines
• Combination Vaccines

By Brand
• Menactra
• Menveo
• NeisVac-C
• Nimenrix
• Others (Meningitec, menAfriVac, Menjugate, and NmVac4-DT)

By End User
• Children
• Preteens or Teens
• Adults

By Region
• North America
o U.S.
o Canada
o Mexico

• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe

• Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific

• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Meningococcal Conjugate Vaccine Market in COVID-19: Implications and Opportunities for Growth in all regions here

News-ID: 2077065 • Views:

More Releases from Allied Market Research

Europe IoT Market is Booming and Predicted to Hit $12.30 Billion by 2031
Europe IoT Market is Booming and Predicted to Hit $12.30 Billion by 2031
The Europe IoT market size was valued at $2.19 billion in 2021, and is projected to reach $12.30 billion by 2031, growing at a CAGR of 19.0% from 2022 to 2031. The cloud-based segment is expected to experience the fastest growth in the coming years, owing to higher adoption of the cloud platform. Organizations are developing and deploying new applications in cloud and moving existing assets at an increasing rate, which
Aerial Imaging Market Size Reach to USD 8.52 Billion by 2030, Growing with 14.2% of CAGR
Aerial Imaging Market Size Reach to USD 8.52 Billion by 2030, Growing with 14.2% …
Rise in demand for aerial imaging in varied commercial applications, surge in use of aerial imaging for disaster risk reduction & prevention, and use of aerial imaging technology in setting up 5G infrastructure drive the growth of the global 𝐀𝐞𝐫𝐢𝐚𝐥 𝐈𝐦𝐚𝐠𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭. However, inaccuracy in image data collection and rise in concerns over cyber-security and data security regarding drones hinder the market growth. On the other hand, surge in demand
Taxi Market is Estimated to Cross US$ 120.89 billion by the End of 2027: Claims AMR
Taxi Market is Estimated to Cross US$ 120.89 billion by the End of 2027: Claims …
𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐓𝐚𝐱𝐢 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟔𝟗.𝟏𝟖 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟏𝟗, 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟏𝟐𝟎.𝟖𝟗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟕, 𝐫𝐞𝐠𝐢𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟐.𝟑% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟎 𝐭𝐨 𝟐𝟎𝟐𝟕. Increase in demand for ride-hailing and ride-sharing services, surge in demand from online taxi booking channels, and rise in cost of vehicle ownership drive the growth of the global taxi market. However, improvement in public transportation and varying government regulations on
Furniture Market is Expected to Witness Healthy Growth at 4% from 2024 to 2034
Furniture Market is Expected to Witness Healthy Growth at 4% from 2024 to 2034
The furniture market is a broad and dynamic industry that encompasses a wide range of products designed for residential, commercial, and institutional use. Furniture is an essential element in both interior design and functionality, catering to various segments such as home, office, hospitality, and outdoor settings. The market is influenced by trends in design, lifestyle changes, technological innovations, and consumer preferences for sustainable and multifunctional products. According to a new report

All 5 Releases


More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the